Pfizer Inc. (PFE)
28.41
+0.23
(+0.82%)
USD |
NYSE |
Sep 24, 16:00
28.42
+0.01
(+0.04%)
After-Hours: 19:59
Pfizer Gross Profit (Annual) : 41.04B for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 41.04B |
| December 31, 2024 | 41.85B |
| December 31, 2023 | 30.34B |
| December 31, 2022 | 62.09B |
| December 31, 2021 | 46.88B |
| December 31, 2020 | 29.88B |
| December 31, 2019 | 28.55B |
| December 31, 2018 | 37.64B |
| December 31, 2017 | 36.77B |
| December 31, 2016 | 36.87B |
| December 31, 2015 | 35.69B |
| December 31, 2014 | 36.30B |
| December 31, 2013 | 37.63B |
| December 31, 2012 | 40.02B |
| December 31, 2011 | 43.87B |
| December 31, 2010 | 46.34B |
| December 31, 2009 | 38.42B |
| December 31, 2008 | 38.26B |
| December 31, 2007 | 36.70B |
| December 31, 2006 | 37.86B |
| December 31, 2005 | 36.90B |
| December 31, 2004 | 41.61B |
| December 31, 2003 | 35.99B |
| Date | Value |
|---|---|
| December 31, 2002 | 28.33B |
| December 31, 2001 | 26.95B |
| December 31, 2000 | 24.23B |
| December 31, 1999 | 13.66B |
| December 31, 1998 | 11.48B |
| December 31, 1997 | 10.19B |
| December 31, 1996 | 9.089B |
| December 31, 1995 | 7.852B |
| December 31, 1994 | 6.363B |
| December 31, 1993 | 5.706B |
| December 31, 1992 | 5.206B |
| December 31, 1991 | 4.749B |
| December 31, 1990 | 4.147B |
| December 31, 1989 | 3.609B |
| December 31, 1988 | 3.365B |
| December 31, 1987 | 3.023B |
| December 31, 1986 | 2.756B |
| December 31, 1985 | 2.479B |
| December 31, 1984 | 2.331B |
| December 31, 1983 | 2.207B |
| December 31, 1982 | 1.921B |
| December 31, 1981 | 1.699B |
| December 31, 1980 | 1.580B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Johnson & Johnson | 64.63B |
| Eli Lilly & Co. | 54.13B |
| Merck & Co., Inc. | 46.73B |
| Bristol Myers Squibb Co. | 31.76B |
| Viatris, Inc. | 5.648B |